Marinus Pharmaceuticals
MRNS
#9855
Rank
A$22.76 M
Marketcap
$0.39
Share price
-5.75%
Change (1 day)
-97.10%
Change (1 year)

Earnings for Marinus Pharmaceuticals (MRNS)

Earnings in 2024 (TTM): -A$0.21 Billion

According to Marinus Pharmaceuticals's latest financial reports the company's current earnings are A$31.46 Million. In 2023 the company made an earning of -A$0.23 Billion a decrease over its 2022 earnings that were of -A$25.79 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Marinus Pharmaceuticals from 2013 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -A$0.21 Billion-6.77%
2023 -A$0.23 Billion770.17%
2022 -A$25.79 Million-83.37%
2021 -A$0.16 Billion46.39%
2020 -A$0.11 Billion24.67%
2019 -A$84.96 Million47.37%
2018 -A$57.66 Million94.33%
2017 -A$29.67 Million-34.02%
2016 -A$44.97 Million15.24%
2015 -A$39.02 Million129.47%
2014 -A$17.01 Million105.55%
2013 -A$8.28 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-A$16.15 Million-92.68%๐Ÿ‡บ๐Ÿ‡ธ USA
A$55.97 M-125.38%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$3.76 Billion 1,602.54%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
A$0.11 B-151.59%๐Ÿ‡บ๐Ÿ‡ธ USA